Electronic health record-based monitoring of primary care patients at risk of medication-related toxicity

Joint Commission Journal on Quality and Patient Safety

Volumn 38, Issue 5, 2012, Pages 216-223

  Bundy, David G ^a,b   Marsteller, Jill A ^c   Wu, Albert W ^a,b   Engineer, Lilly D ^a   Berenholtz, Sean M ^a   Caughey, A Harrison ^c   Silver, David ^d   Tian, Jing ^e   Thompson, Richard E ^f   Miller, Marlene R ^a   Lehmann, Christoph U ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Department of Health Policy and Management ^*  (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Johns Hopkins Bloomberg   (United States)

^f Department of Biostatistics and Executive   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DRUG MONITORING; DRUG TOXICITY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CENTER; HEALTH INSURANCE; HUMAN; INSURANCE; MALE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; STATISTICS; UNITED STATES;

ADULT; AGED; BALTIMORE; COMMUNITY HEALTH CENTERS; DRUG MONITORING; DRUG TOXICITY; FEMALE; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PRIMARY HEALTH CARE;

EID: 84862208476     PISSN: 15537250     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1553-7250(12)38027-6     Document Type: Article

References (33)

1. Gurwitz JH, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 Mar 5;289(9): 1107-1116. (Pubitemid 37430324)
2. Field TS, et al. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005;43(12):1171-1176. (Pubitemid 43012173)
3. Gandhi TK, et al. Drug complications in outpatients. J Gen Intern Med. 2000;15(3):149-154. (Pubitemid 30155346)
4. Gandhi TK, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003 Apr 17;348(16):1556-1564. (Pubitemid 36437933)
5. Jha AK, et al. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf. 2001;10(2): 113-119. (Pubitemid 32590942)
6. Forster AJ, et al. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005;20(4):317-323. (Pubitemid 40617599)
7. Aspden P, et al.; Institute of Medicine, Committee on Identifying and Preventing Medication Errors. Preventing Medication Errors. Washington, DC: National Academies Press, 2007.
8. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: A systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017-1025.
9. Buettner C, Lecker SH. Molecular basis for statin-induced muscle toxicity: Implications and possibilities. Pharmacogenomics. 2008;9(8):1133-1142.
10. . Oake N, et al. Effect of an interactive voice response system on oral anticoagulant management. CMAJ. 2009 Apr 28;180(9):927-933.
11. Phillips KW, Ansell J. Outpatient management of oral vitamin K antagonist therapy: Defining and measuring high-quality management. Expert Rev Cardiovasc Ther. 2008;6(1):57-70.
12. Bradbury MJ, et al. A comparative study of anticoagulant control in patients on long-Term warfarin using home and hospital monitoring of the international normalized ratio. Arch Dis Child. 2008;93(4):303-306. (Pubitemid 352025827)
13. Ansell JE, Hughes R. Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J. 1996;132(5):1095-1100. (Pubitemid 26372785)
14. National Committee for Quality Assurance. HEDIS 2010. 2009. Accessed Mar 14, 2012. http://www.ncqa.org/tabid/1044/Default.aspx.
15. Raebel MA, et al. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med. 2005;20(12):1120-1126. (Pubitemid 43110262)
16. Raebel MA, et al. Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care. 2006;12(5):268-274.
17. Raebel MA, et al. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: Are we monitoring for hyperkalemia? Ann Pharmacother. 2007;41(2):193-200. (Pubitemid 46340049)
18. Raebel MA, et al. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf. 2007;16(1):55-64. (Pubitemid 46164976)
19. Hurley JS, et al. Laboratory safety monitoring of chronic medications in ambulatory care settings. J Gen Intern Med. 2005;20(4):331-333. (Pubitemid 40617601)
20. Raebel MA, et al. Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs. J Manag Care Pharm. 2006;12(8):656-664. (Pubitemid 47400562)
21. Feldstein AC, et al. Improved therapeutic monitoring with several interventions: A randomized trial. Arch Intern Med. 2006 Sep 25;166(17): 1848-1854. (Pubitemid 44455167)
22. Palen TE, et al. Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders. Am J Manag Care. 2006;12(7):389-395. (Pubitemid 44061011)
23. Lo HG, et al. Impact of non-interruptive medication laboratory monitoring alerts in ambulatory care. J Am Med Inform Assoc. 2009;16(1):66-71.
24. Raebel MA, et al. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: A randomized trial. Arch Intern Med. 2005 Nov 14;165(20):2395-2401. (Pubitemid 41640852)
25. Fischer SH, Tjia J, Field TS. Impact of health information technology interventions to improve medication laboratory monitoring for ambulatory patients: A systematic review. J Am Med Inform Assoc. 2010;17(6):631-636.
26. Stelfox HT, et al. An evaluation of the adequacy of outpatient monitoring of thyroid replacement therapy. J Eval Clin Pract. 2004;10(4):525-530. (Pubitemid 39469036)
27. Raebel MA, et al. Diabetes and drug-Associated hyperkalemia: Effect of potassium monitoring. J Gen Intern Med. 2010;25(4):326-333.
28. Jamtvedt G, et al. Audit and feedback: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000259.
29. Hysong SJ. Meta-Analysis: Audit and feedback features impact effectiveness on care quality. Med Care. 2009;47(3):356-363.
30. Smith DH, et al. Improving laboratory monitoring of medications: An economic analysis alongside a clinical trial. Am J Manag Care. 2009;15(5): 281-289.
31. Morrato EH, et al. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010;67(1):17-24.
32. Cabana MD, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999 Oct 20;282(15):1458-1465. (Pubitemid 29493800)
33. US Government Printing Office. Medicare and Medicaid Programs; Electronic Health Record Incentive Program; Proposed Rule. Centers for Medicare & Medicaid Services. Jan 13, 2010. Accessed Mar 14, 2012. http://edocket .access.gpo.gov/2010/E9-31217.htm.